{
    "nctId": "NCT00897208",
    "briefTitle": "Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer",
    "officialTitle": "Estrogen-DNA Adducts in Breast, Urine and Serum as Biomarkers of Breast Cancer Risk",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 316,
    "primaryOutcomeMeasure": "Comparison of the levels of estrogens, catechol estrogen (CE) metabolites, CE-glutathione conjugates, and CE-DNA adducts (N3Ade and N7Gua) among healthy women, high-risk women, and women with breast cancer",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Meets 1 of the following criteria:\n\n  * Newly diagnosed (within 30 calendar days of diagnosis) stage I or II breast cancer\n\n    * Node-negative or node-positive disease\n  * Newly diagnosed ductal carcinoma in situ (stage 0) of the breast\n  * At high risk of developing breast cancer, as indicated by at least 1 of the following criteria:\n\n    * Gail model 5-year risk score \u2265 1.66%\n    * Gail model lifetime-risk estimate \u2265 20%\n    * Known deleterious BRCA 1 or 2 gene mutation carrier\n    * History of lobular carcinoma in situ or atypical ductal or lobular hyperplasia\n  * At low or average risk of developing breast cancer (control group)\n\n    * Gail model 5-year risk score \\< 1.66% or lifetime risk \\< 20%\n* No advanced breast cancer\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Pre- or post-menopausal\n\nPRIOR CONCURRENT THERAPY:\n\n* No prior chemotherapy for breast cancer or any other cancer\n* More than 3 months since prior and no concurrent estrogen or other hormones\n* More than 3 months since prior oral contraceptives\n* No concurrent selective estrogen receptor modulators (tamoxifen citrate or raloxifene)\n* No concurrent aromatase inhibitors",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}